215 related articles for article (PubMed ID: 32739616)
1. Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP/TAZ/JNK signaling pathway in endothelial cells and pericytes.
Yang Y; Pei K; Zhang Q; Wang D; Feng H; Du Z; Zhang C; Gao Z; Yang W; Wu J; Li Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158779. PubMed ID: 32739616
[TBL] [Abstract][Full Text] [Related]
2. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
[TBL] [Abstract][Full Text] [Related]
3. Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation.
Yang Y; Wang D; Zhang C; Yang W; Li C; Gao Z; Pei K; Li Y
Hum Cell; 2022 Jan; 35(1):51-62. PubMed ID: 34606042
[TBL] [Abstract][Full Text] [Related]
4. Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway.
Zhao H; Liu M; Liu H; Suo R; Lu C
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32091090
[TBL] [Abstract][Full Text] [Related]
5. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J
Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081
[TBL] [Abstract][Full Text] [Related]
6. Salvianolic acid B attenuates the inflammatory response in atherosclerosis by regulating MAPKs/ NF-κB signaling pathways in LDLR-/- mice and RAW264.7 cells.
Zhang Y; Feng X; Du M; Ding J; Liu P
Int J Immunopathol Pharmacol; 2022; 36():3946320221079468. PubMed ID: 35285334
[No Abstract] [Full Text] [Related]
7. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow.
Liu D; Lv H; Liu Q; Sun Y; Hou S; Zhang L; Yang M; Han B; Wang G; Wang X; Du W; Nie H; Zhang R; Huang X; Hou J; Yu B
J Transl Med; 2019 Nov; 17(1):378. PubMed ID: 31730006
[TBL] [Abstract][Full Text] [Related]
8. Biomimetic nanodrug targets inflammation and suppresses YAP/TAZ to ameliorate atherosclerosis.
Huang HC; Wang TY; Rousseau J; Orlando M; Mungaray M; Michaud C; Plaisier C; Chen ZB; Wang KC
Biomaterials; 2024 Apr; 306():122505. PubMed ID: 38359507
[TBL] [Abstract][Full Text] [Related]
9. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases.
Yu Y; Su X; Qin Q; Hou Y; Zhang X; Zhang H; Jia M; Chen Y
Pharmacol Res; 2020 Sep; 159():105009. PubMed ID: 32553712
[TBL] [Abstract][Full Text] [Related]
10. Sal B targets TAZ to facilitate osteogenesis and reduce adipogenesis through MEK-ERK pathway.
Wang N; Li Y; Li Z; Liu C; Xue P
J Cell Mol Med; 2019 May; 23(5):3683-3695. PubMed ID: 30907511
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
[TBL] [Abstract][Full Text] [Related]
12. MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis.
Yang L; Gao C
Yonsei Med J; 2019 Mar; 60(3):298-307. PubMed ID: 30799593
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) mediate cell density-dependent proinflammatory responses.
Zhang Q; Han X; Chen J; Xie X; Xu J; Zhao Y; Shen J; Hu L; Xu P; Song H; Zhang L; Zhao B; Wang YJ; Xia Z
J Biol Chem; 2018 Nov; 293(47):18071-18085. PubMed ID: 30315101
[TBL] [Abstract][Full Text] [Related]
14. Oxidized low-density lipoprotein promotes vascular endothelial cell dysfunction by stimulating miR-496 expression and inhibiting the Hippo pathway effector YAP.
Hu J; Liu T; Zhang Z; Xu Y; Zhu F
Cell Biol Int; 2019 May; 43(5):528-538. PubMed ID: 30811087
[TBL] [Abstract][Full Text] [Related]
15. YAP and TAZ protect against white adipocyte cell death during obesity.
Wang L; Wang S; Shi Y; Li R; Günther S; Ong YT; Potente M; Yuan Z; Liu E; Offermanns S
Nat Commun; 2020 Oct; 11(1):5455. PubMed ID: 33116140
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
[TBL] [Abstract][Full Text] [Related]
17. TNF-α-Induced YAP/TAZ Activity Mediates Leukocyte-Endothelial Adhesion by Regulating VCAM1 Expression in Endothelial Cells.
Choi HJ; Kim NE; Kim BM; Seo M; Heo JH
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30388809
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin attenuate cerebral microvascular leakage by regulating inflammation and apoptosis potentially via a p38 MAPK-JNK dependent pathway.
Wu CR; Yang QY; Chen QW; Li CQ; He WY; Zhao YP; Wang L
Biochem Biophys Res Commun; 2021 May; 552():37-43. PubMed ID: 33740663
[TBL] [Abstract][Full Text] [Related]
19. VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.
Xu K; Zhao H; Qiu X; Liu X; Zhao F; Zhao Y
Mediators Inflamm; 2020; 2020():8292173. PubMed ID: 33456372
[TBL] [Abstract][Full Text] [Related]
20. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells.
Xu S; Koroleva M; Yin M; Jin ZG
Transl Res; 2016 Oct; 176():18-28.e2. PubMed ID: 27295628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]